These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9403276)

  • 1. Who cares about pharmacovigilance?
    Edwards IR
    Eur J Clin Pharmacol; 1997; 53(2):83-8. PubMed ID: 9403276
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacovigilance in the pharmaceutical industry.
    Talbot JC; Nilsson BS
    Br J Clin Pharmacol; 1998 May; 45(5):427-31. PubMed ID: 9643613
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern methods of pharmacovigilance: detecting adverse effects of drugs.
    Norén GN; Edwards IR
    Clin Med (Lond); 2009 Oct; 9(5):486-9. PubMed ID: 19886114
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring and managing adverse drug reactions.
    Fincham JE
    Am Pharm; 1992 Feb; NS32(2):74-81. PubMed ID: 1546634
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
    Schäublin M
    Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National pharmacovigilance program.
    Bavdekar SB; Karande S
    Indian Pediatr; 2006 Jan; 43(1):27-32. PubMed ID: 16465003
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicine Safety Monitoring in Pediatric Population in India.
    Kaur I; Kalaiselvan V; Singh GN
    Indian J Pediatr; 2016 May; 83(5):479-80. PubMed ID: 26634262
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription-event monitoring and reporting of adverse drug reactions.
    Heeley E; Riley J; Layton D; Wilton LV; Shakir SA
    Lancet; 2001 Dec; 358(9296):1872-3. PubMed ID: 11741629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wonder vigilance.
    Edwards IR
    Drug Saf; 2010 Feb; 33(2):83-6. PubMed ID: 20088622
    [No Abstract]   [Full Text] [Related]  

  • 10. [The French pharmacovigilance system: structure and missions].
    Welsch M; Alt M; Richard MH; Imbs JL
    Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The organization of pharmacovigilance in France, in Europe and worldwide - From label to delivery of an innovative treatment: what a journey! (3)].
    Lebrun-Vignes B
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():37-39. PubMed ID: 30943161
    [No Abstract]   [Full Text] [Related]  

  • 12. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
    Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIDOS: a mechanistic classification of adverse drug effects.
    Ferner RE; Aronson JK
    Drug Saf; 2010 Jan; 33(1):15-23. PubMed ID: 20000863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists.
    Lemay J; Alsaleh FM; Al-Buresli L; Al-Mutairi M; Abahussain EA; Bayoud T
    Med Princ Pract; 2018; 27(1):30-38. PubMed ID: 29402876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting adverse drug reaction reporting: comparison of different approaches.
    Ribeiro-Vaz I; Santos CC; Cruz-Correia R
    Rev Saude Publica; 2016; 50():14. PubMed ID: 27143614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country.
    Nguyen KD; Nguyen PT; Nguyen HA; Roussin A; Montastruc JL; Bagheri H; Olsson S
    Drug Saf; 2018 Feb; 41(2):151-159. PubMed ID: 28975584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonisation in pharmacovigilance.
    Edwards IR; Biriell C
    Drug Saf; 1994 Feb; 10(2):93-102. PubMed ID: 8011183
    [No Abstract]   [Full Text] [Related]  

  • 19. French pharmacovigilance: Missions, organization and perspectives.
    Vial T
    Therapie; 2016 Apr; 71(2):143-50. PubMed ID: 27080832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publicly accessible pharmacovigilance databases.
    Prescrire Int; 2012 Apr; 21(126):99. PubMed ID: 22515136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.